Download PDF
Planta Med 1997; 63(6): 525-528
DOI: 10.1055/s-2006-957755
Papers
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Anti-Inflammatory and Analgesic Effects of Cucurbitacins from Wilbrandia ebracteata

Rodrigo Rebelo Peters1 , Mareni Rocha Farias2 , Rosa Ma Ribeiro-do-Valle1
  • 1Department of Pharmacology, Centre of Biological Sciences, Universidade Federal de Santa Catarina, Ferreira Lima, 82, 88015-420, SC, Brazil
  • 2Department of Pharmaceutics Sciences; Centre of Health Sciences, Universidade Federal de Santa Catarina, 88049-900 Florianopolis, Brazil
Further Information

Publication History

1996

1997

Publication Date:
04 January 2007 (online)

  PDF Download  Permissions and Reprints

Abstract

The anti-inflammatory and antinociceptive actions of the CH2Cl2 extract and semipurified fraction (F-III) from roots of Wilbrandia ebracteata Cogn. have been investigated in rats and mice. The CH2Cl2 extract (1-10 mg/kg, i.p.; ID50 5 mg/kg) and (3-30 mg/kg, p.o.; ID50 15 mg/kg) inhibited, in a dose-related manner, carrageenan-induced paw edema in rats. The subfraction (F-III) from CH2Cl2 extract and compounds isolated as cucurbitacin B and E also inhibited carrageenan-induced edema. The CH2Cl2 extract and F-III also exhibited significant analgesic action in acetic acid-induced pain in mice. In the formalin test, the CH2Cl2 extract (0.3-10 mg/kg, i.p.) and (3-30 mg/kg, p.o.) caused inhibition of the neurogenic (first phase) and inflammatory phase (second phase) of formalin-induced pain. However, the CH2Cl2 extract was more effective in relation to the second phase than in inhibition of the formalin-induced edema. These findings suggest that CH2Cl2 extract has potent anti-inflammatory and analgesic action and that F-III and cucurbitacin B and E may account for these actions.

Key words

Wilbrandia ebracteata - Cucurbitaceae - cucurbitacin B and E - anti-inflammatory - analgesic

      >